Back to Search
MARK KOWAL, M.D.
M.D.
Surgery Physician
NPI: 1285855239IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
7319(AK)
Education
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Class of 2006
Research & Publications (20)
[Recent progress in prognostic markers and treatment of chronic lymphocytic leukemia].
PMID 18652284·Pol Arch Med Wewn·2006
6-review
Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study.
PMID 15359995·Leuk Lymphoma·2004
4-observational
Immunohistochemical localization of androgen receptors in testicular cells of mice with mosaic mutation.
PMID 12056625·Folia Histochem Cytobiol·2002
7-preclinical
Day/night food consumption in mice is strain and age-dependent.
PMID 12597524·Folia Biol (Krakow)·2002
7-preclinical
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
PMID 19440214·Leukemia·2009
8-other
CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
PMID 19240243·Cancer Epidemiol Biomarkers Prev·2009
8-other
Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures.
PMID 18977529·Leuk Res·2009
8-other
The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
PMID 18499249·Leuk Res·2008
8-other
The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide.
PMID 17657216·Leukemia·2008
8-other
Acute T cell lymphoblastic leukemia in the recipient of a renal transplant from a donor with malignant lymphoma.
PMID 18536518·Acta Haematol·2008
5-case
Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
PMID 18695923·Oncol Rep·2008
4-observational
[Obstacles to medication compliance for patients with glaucoma].
PMID 19195163·Klin Oczna·2008
8-other
Testicular morphology and expression of aromatase in testes of mice with the mosaic mutation (Atp7a mo-ms).
PMID 17045330·Theriogenology·2007
7-preclinical
Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL).
PMID 16906577·Cytometry B Clin Cytom·2006
4-observational
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
PMID 16551966·Blood·2006
4-observational
IL-6 and FAS (CD95) serum level in patients suffering from psoriasis and in relation to the lymphocyte subpopulations.
PMID 16146038·Ann Univ Mariae Curie Sklodowska Med·2004
8-other
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).
PMID 12930315·Eur J Haematol·2003
3-trial
Pathological structure of the kidney from adult mice with mosaic mutation.
PMID 12705495·J Inherit Metab Dis·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1919 LATHROP ST, SUITE 202
FAIRBANKS, AK 99701 - Phone
- (907) 451-5507
Quick Facts
- NPI
- 1285855239
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile